In its cover article for the March edition of the ASH Clinical News magazine, ASH takes a deep dive into the realm of cost-effectiveness analyses for healthcare interventions.
The article features insights from a range of professionals, including Steven Pearson, president of the Institute for Clinical and Economic Review (ICER).
“We are benefiting from a rich pipeline of innovative and wonderful new medications,” Pearson said. “The challenge is finding that sweet spot where we maintain access and affordability for individual patients and for the health-care system – because we will never have unlimited resources to spend on health – but also incentivize innovation and keep that pipeline flowing.”
To read the article, click here.